HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 6,500 shares, a growth of 170.8% from the November 30th total of 2,400 shares. Based on an average daily volume of 11,300 shares, the days-to-cover ratio is currently 0.6 days.
HAVN Life Sciences Price Performance
HAVLF traded up $0.02 on Thursday, hitting $0.06. 6,005 shares of the company were exchanged, compared to its average volume of 5,798. The firm has a fifty day simple moving average of $0.06 and a two-hundred day simple moving average of $0.50. HAVN Life Sciences has a 12 month low of $0.04 and a 12 month high of $4.59.
Get HAVN Life Sciences alerts:About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.Featured Stories
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
- Tesla Stock: What the Bulls and the Bears Are Getting Wrong
- Big Health Care Stocks to Watch in the New Year
- The Top Three Stocks Analysts Say To Buy
- Can Dick's Sporting Goods Stock Score Another Win In Q4?
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.